COMPASS PATHWAYS PLC Shares Outstanding (Cover Page)
COMPASS PATHWAYS PLC (CMPS) had Shares Outstanding (Cover Page) of 138.48 million shares as of 2026-07-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-30: Entity Common Stock, Shares Outstanding 138.48M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 134.95M shares.
- 2026-03-17: Entity Common Stock, Shares Outstanding 128.92M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 96.02M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 138.48M shares 10-Q · filed 2026-08-05 |
| 2026-05-06 | 134.95M shares 10-Q · filed 2026-05-13 |
| 2026-03-17 | 128.92M shares 10-K · filed 2026-03-24 |
| 2025-10-30 | 96.02M shares 10-Q · filed 2025-11-04 |
| 2025-07-28 | 95.94M shares 10-Q · filed 2025-07-31 |
| 2025-05-06 | 93.56M shares 10-Q · filed 2025-05-08 |
| 2025-02-24 | 92.67M shares 10-K · filed 2025-02-27 |
| 2024-10-28 | 68.42M shares 10-Q · filed 2024-10-31 |
| 2024-07-29 | 68.39M shares 10-Q · filed 2024-08-01 |
| 2024-05-06 | 68.38M shares 10-Q · filed 2024-05-08 |
| 2024-02-23 | 64.23M shares 10-K · filed 2024-02-29 |
| 2023-10-30 | 61.90M shares 10-Q · filed 2023-11-02 |
| 2023-07-31 | 45.78M shares 10-Q · filed 2023-08-03 |
| 2023-05-09 | 45.62M shares 10-Q · filed 2023-05-11 |
| 2023-02-22 | 42.76M shares 10-K · filed 2023-02-28 |
| 2022-11-02 | 42.58M shares 10-Q · filed 2022-11-03 |
| 2022-08-03 | 42.52M shares 10-Q · filed 2022-08-04 |
| 2022-05-06 | 42.51M shares 10-Q · filed 2022-05-10 |
| 2022-02-17 | 42.02M shares 10-K · filed 2022-02-24 |
| 2020-12-31 | 35.93M shares 20-F · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |